Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Selling, General, & Admin. Expense: €3.91 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TJJ Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
28 GF Score
Price €0.02
GF Value €0.01
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense?

Tianjin TEDA Biomedical Engineering Co FRA:TJJ -2.27% 28 Selling, General, & Admin. Expense is €3.91 Mil as of Dec. 2025. GuruFocus rates FRA:TJJ with a GF Score™ of 28/100 and a GF Value™ of €0.01 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Tianjin TEDA Biomedical Engineering Co's selling, general, & admin. expense for the six months ended in Dec. 2025 was €3.43 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2025 was €3.91 Mil.


Tianjin TEDA Biomedical Engineering Co  (FRA:TJJ) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense Related Terms


Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense Chart

Tianjin TEDA Biomedical Engineering Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.78 4.50 3.84 4.49 3.91

Tianjin TEDA Biomedical Engineering Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.16 0.90 3.57 0.48 3.43

FRA:TJJ vs CTVA, CF, MOS: Selling, General, & Admin. Expense Comparison

For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense falls into.


FRA:TJJ
28GF Score
Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin TEDA Biomedical Engineering Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of €3.91 Mil mean?
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) has a Selling, General, & Admin. Expense of €3.91 Mil as of Dec. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors.
Is Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense too high?
Tianjin TEDA Biomedical Engineering Co's current Selling, General, & Admin. Expense is €3.91 Mil. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense compare to CTVA and CF?
Tianjin TEDA Biomedical Engineering Co's Selling, General, & Admin. Expense of €3.91 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for an Agriculture company?
A good Selling, General, & Admin. Expense depends on the Agriculture industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. Tianjin TEDA Biomedical Engineering Co's current Selling, General, & Admin. Expense is €3.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 115% above its estimated fair value. The current Selling, General, & Admin. Expense is €3.91 Mil. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (FRA:TJJ), the current Selling, General, & Admin. Expense is €3.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued. The current stock price of €0.02 is trading 115% above its estimated GF Value™ of €0.01. GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.

Key valuation signals for FRA:TJJ:

  • Selling, General, & Admin. Expense: €3.91 Mil
  • GF Value™: €0.01 vs. price of €0.02 (115% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the FRA:TJJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tianjin TEDA Biomedical Engineering Co Business Description

Other Exchanges 08189:Hong Kong
Address No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score

Get the complete analysis for FRA:TJJ

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.01
GF Value